Stressful experience during early brain development has been shown to produce profound alterations in several mechanisms of adaptation, while several signs of behavioral and neuroendocrine impairment resulting from neonatal exposure to stress resemble symptoms of dysregulation associated with major depression. This study demonstrates that when applied concomitantly with the stressful challenge, the steroid GABA(A) receptor agonist 3,21-dihydropregnan-20-one (tetrahydrodeoxycorticosterone, THDOC) can attenuate the behavioral and neuroendocrine consequences of repeated maternal separation during early life, e.g., increased anxiety, an exaggerated adrenocortical secretory response to stress, impaired responsiveness to glucocorticoid feedback, and altered transcription of the genes encoding corticotropin-releasing hormone (CRH) in the hypothalamus and glucocorticoid receptors in the hippocampus. These data indicate that neuroactive steroid derivatives with GABA-agonistic properties may exert persisting stress-protective effects in the developing brain, and may form the basis for therapeutic agents which have the potential to prevent mental disorders resulting from adverse experience during neonatal life.
V K Patchev, A Montkowski, D Rouskova, L Koranyi, F Holsboer, O F Almeida
Title and authors | Publication | Year |
---|---|---|
Neurophysiologic consequences of neonatal ethanol exposure in the rat
CJ Slawecki, JD Thomas, EP Riley, CL Ehlers |
Alcohol | 2004 |
Effects of the active neurosteroid allotetrahydrodeoxycorticosterone on long-term potentiation in the rat hippocampus: implications for depression
B Dubrovsky, A Tatarinov-Levin, J Harris |
Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2004 |
Role of progesterone and other neuroactive steroids in anxiety disorders
JM Mellédo, G Baker |
Expert Review of Neurotherapeutics | 2004 |
Sexually dimorphic effects of postnatal allopregnanolone on the development of anxiety behavior after early deprivation
B Zimmerberg, EW Kajunski |
Pharmacology Biochemistry and Behavior | 2004 |
Disadaptive disorders in women: allopregnanolone, a sensitive steroid
F Bernardi, N Pluchino, S Begliuomini, E Lenzi, M Palumbo, M Luisi, AR Genazzani |
Gynecological Endocrinology | 2004 |
Panic Induction with Cholecystokinin-Tetrapeptide (CCK-4) Increases Plasma Concentrations of the Neuroactive Steroid 3α, 5α Tetrahydrodeoxycorticosterone (3α, 5α-THDOC) in Healthy Volunteers
D Eser, F Michele, P Zwanzger, A Pasini, TC Baghai, C Schüle, R Rupprecht, E Romeo |
Neuropsychopharmacology | 2004 |
Psychotrauma
A Friedmann, P Hofmann, B Lueger-Schuster, M Steinbauer, D Vyssoki |
2004 | |
Early postnatal corticosterone administration regulates neurotrophins and their receptors in septum and hippocampus of the rat
T Roskoden, U Otten, H Schwegler |
Experimental Brain Research | 2004 |